Most proteases are expressed as inactive precursors, known as zymogens. Studies to explore zymogen activation can further elucidate biological regulatory mechanisms and lead to novel chemical biology tools to trigger them. Caspases, or cysteine aspartyl proteases, are expressed as such inactive precursors, or procaspases, which become activated in fate-determining transformations, such as apoptosis. Procaspases are naturally activated upon binding to scaffolding complexes or as a result of cleavage by upstream proteases in response to extrinsic or intrinsic cellular signals. Removal of an N-terminal prodomain and an additional cleavage to yield a large and small subunit generates the mature enzyme. A small molecule, termed 1541, was identif...
One key hallmark of cancer is its ability to evade apoptotic cell death. In normal cells, the apopto...
ABSTRACT: Combination anticancer therapy typically con-sists of drugs that target different biochemi...
180 p.Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 2008.Programmed cell death, also k...
Most proteases are expressed as inactive precursors, or zymogens, that become activated by limited p...
Caspases are cysteine proteases that play an essential role in apoptosis. Initial activation of casp...
SummaryCaspases are proteases with an active-site cysteine and aspartate specificity in their substr...
Caspases are proteases at the heart of networks that govern apoptosis and inflammation. The past dec...
Apoptosis is a conserved cellular pathway that results in the activation of cysteine-aspartyl protea...
The balance of pro-apoptotic and pro-survival proteins defines a cell\u27s fate. These processes are...
Mutation and aberrant expression of apoptotic proteins are hallmarks of cancer. These changes preven...
SummaryApoptosis is a conserved cellular pathway that results in the activation of cysteine-aspartyl...
Switching on pro‐proteases: Direct small‐molecule activation of proenzymes such as pro‐proteases has...
Switching on pro‐proteases: Direct small‐molecule activation of proenzymes such as pro‐proteases has...
AbstractApoptosis is primarily executed by active caspases, which are derived from the inactive proc...
BackgroundThe caspase-mediated proteolysis of many cellular proteins is a critical event during prog...
One key hallmark of cancer is its ability to evade apoptotic cell death. In normal cells, the apopto...
ABSTRACT: Combination anticancer therapy typically con-sists of drugs that target different biochemi...
180 p.Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 2008.Programmed cell death, also k...
Most proteases are expressed as inactive precursors, or zymogens, that become activated by limited p...
Caspases are cysteine proteases that play an essential role in apoptosis. Initial activation of casp...
SummaryCaspases are proteases with an active-site cysteine and aspartate specificity in their substr...
Caspases are proteases at the heart of networks that govern apoptosis and inflammation. The past dec...
Apoptosis is a conserved cellular pathway that results in the activation of cysteine-aspartyl protea...
The balance of pro-apoptotic and pro-survival proteins defines a cell\u27s fate. These processes are...
Mutation and aberrant expression of apoptotic proteins are hallmarks of cancer. These changes preven...
SummaryApoptosis is a conserved cellular pathway that results in the activation of cysteine-aspartyl...
Switching on pro‐proteases: Direct small‐molecule activation of proenzymes such as pro‐proteases has...
Switching on pro‐proteases: Direct small‐molecule activation of proenzymes such as pro‐proteases has...
AbstractApoptosis is primarily executed by active caspases, which are derived from the inactive proc...
BackgroundThe caspase-mediated proteolysis of many cellular proteins is a critical event during prog...
One key hallmark of cancer is its ability to evade apoptotic cell death. In normal cells, the apopto...
ABSTRACT: Combination anticancer therapy typically con-sists of drugs that target different biochemi...
180 p.Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 2008.Programmed cell death, also k...